🇺🇸 FDA
Pipeline program

artemether-lumefantrine (ALN)

IRB00014153

Approved small_molecule completed

Quick answer

artemether-lumefantrine (ALN) for Uncomplicated Malaria is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Uncomplicated Malaria
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials